If you have been shopping for peptides through a telehealth clinic or compounding pharmacy, you may have noticed the ground shifting. Some compounds that were easy to find a year or two ago are now harder to get through legitimate channels. That is not random. It reflects specific regulatory decisions about which substances pharmacies can compound and sell.
This piece is for the reader who wants to buy legally, through a licensed pharmacy and a valid prescription, and wants to understand the current status of the peptides most often discussed. We are not going to make health claims or give you numbers to inject. We are going to describe where things stand and how to vet who you are dealing with.
The two categories that matter
Almost every question about legitimacy comes down to one distinction. Is the substance an FDA-approved drug, or is it an investigational compound that a pharmacy is choosing to prepare? Those are very different legal situations, and the answer changes how you should think about cost and safety.
FDA-approved drugs have gone through human trials, carry approved labeling, and are manufactured under federal oversight. Investigational peptides have not cleared that bar. A compounding pharmacy may still prepare some of them, but the legal footing is narrower and, in several cases, actively contested.
Where the named peptides stand
Semaglutide and tirzepatide are the GLP-1 medications you have seen in the news. Both exist as FDA-approved branded products. Compounded versions became widely available during official shortages, but the FDA has since declared those shortages resolved, which sharply limits when a pharmacy may legally compound them. If a provider is offering a compounded GLP-1, ask directly what legal basis they are relying on and expect a clear answer.
BPC-157 is investigational. It has been the subject of specific regulatory scrutiny, and its status for compounding has been restricted rather than expanded. CJC-1295 is likewise investigational and not an approved drug. Thymosin alpha-1 sits in a similar investigational category. None of these has the approval status that the branded GLP-1 products carry, and availability through licensed pharmacies has been narrowing rather than widening.
What actually drives the price
Cost is not just the raw peptide. For approved drugs, you are paying for a manufacturer's branded product, and the price reflects that supply chain. For compounded preparations, you are paying a pharmacy for formulation, testing, and dispensing, plus the clinical visit that generates the prescription. When a compound becomes harder to source legally, prices tend to reflect that scarcity, and unusually cheap offers are a warning sign, not a bargain.
Be skeptical of any seller pricing below what a legitimate operation could sustain. Research-use-only vendors often undercut licensed pharmacies precisely because they skip the testing, the prescription, and the accountability. Those products are not sold for human use, and buying from them is not the same as filling a prescription.
How to vet a provider
The good news is that vetting is mostly about asking direct questions and watching how a provider answers. A legitimate operation will not flinch at any of these.
- Is there a licensed clinician who evaluates you and writes an actual prescription, or is the consult a formality?
- Which licensed pharmacy dispenses the product, and is it a 503A or 503B facility?
- For any compounded GLP-1, what specific legal basis are they using now that shortages are resolved?
- Will they name the source and provide testing documentation for what you receive?
- Do they explain that these compounds are investigational rather than promising outcomes?
A provider that answers plainly is showing you its work. One that dodges, rushes you, or leans on marketing language is telling you something too.
The practical takeaway
The red light you are seeing is regulators drawing lines between approved drugs and investigational compounds, and between shortage-era compounding and its aftermath. For you, the comparison shopper, the durable move is to work with a licensed clinician and a licensed pharmacy, insist on a real prescription, and treat any channel that skips those steps as off the table. None of this is medical advice. Decisions about your own care belong with a clinician who knows your history.